THE PROGNOSTIC SIGNIFICANCE OF FDG-PET IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Bae, S. H. [1 ]
Ryoo, H. M. [1 ]
机构：
[1] Daegu Catholic Univ Hosp, Taegu, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [41] The prognostic value of FDG uptake of metastatic tumors in patients with advanced non-small cell lung cancer
    Li, Yuxin
    Tafti, Bashir
    Shaba, Wisam
    Berenji, Gholam
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [42] Mid-treatment FDG-PET predicts disease progression in patients with non-small cell lung cancer
    Olson, M. R.
    Weerasuriya, D. K.
    Wakelee, H. A.
    Quon, A.
    Maxim, P. G.
    Le, Q.
    Graves, E. E.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S504 - S504
  • [43] FDG-PET as an early surrogate marker for response to chemotherapy in patients with non-small cell lung cancer.
    Weber, WA
    Petersen, V
    Tyndale-Hines, L
    Peschel, C
    Schwaiger, M
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 301P - 301P
  • [44] FDG-PET response to nivolumab is predictive of tumor progression and survival in non-small cell lung cancer patients
    Seraj, Siavash Mehdizadeh
    Zadeh, Mandi Zirakchian
    Jahangiri, Pegah
    Kaghazchi, Fatemeh
    Kalboush, Eman
    Werner, Thomas
    Newberg, Andrew
    Hunt, Stephen
    Alavi, Abass
    Revheim, Mona-Elisabeth
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [45] Evaluation of efficacy and clinical impact of FDG-PET on patients with potentially resectable non-small cell lung cancer
    Dorado, I. Borrego
    Garcia, C. Lopez
    Albertino, R. Vazquez
    Canamaque, A. Ginel
    Cortes, E. Barrot
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2007, 26 (06): : 335 - 344
  • [46] FDG PET of pleural effusions in patients with non-small cell lung cancer
    Erasmus, JJ
    McAdams, HP
    Rossi, SE
    Goodman, PC
    Coleman, RE
    Patz, EF
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 175 (01) : 245 - 249
  • [47] FDG-PET SUVmax Does Not Correlate with Glucose Metabolism in Non-Small Cell Lung Cancer
    Kernstine, Kemp
    Faubert, Brandon
    Hensley, Christopher
    Cai, Ling
    Torrealba, Jose
    Oliver, Dwight
    Lenkinski, Robert
    Malloy, Craig
    Deberardinis, Ralph
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S554 - S554
  • [48] FDG-PET Follow-up of Non-Small Cell Lung Cancer: Not Dead Yet
    Stirling, Rob G.
    Zalcberg, John
    ANNALS OF THORACIC SURGERY, 2020, 109 (05): : 1624 - 1624
  • [49] FDG-PET and CT features of non-small cell lung cancer based on tumor type
    Aquino, Suzanne L.
    Halpern, Elkan F.
    Kuester, Landon B.
    Fischman, Alan J.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 19 (03) : 495 - 499
  • [50] Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer
    Sunaga, Noriaki
    Oriuchi, Noboru
    Kaira, Kyoichi
    Yanagitani, Noriko
    Tomizawa, Yoshio
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Endo, Keigo
    Mori, Masatomo
    LUNG CANCER, 2008, 59 (02) : 203 - 210
12345